Boston Partners Invests $3.32 Million in CVS Health Corporation $CVS

Boston Partners bought a new stake in CVS Health Corporation (NYSE:CVS) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 48,195 shares of the pharmacy operator’s stock, valued at approximately $3,324,000.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Avion Wealth lifted its position in shares of CVS Health by 99.0% in the second quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 189 shares during the last quarter. Harbor Asset Planning Inc. acquired a new position in shares of CVS Health during the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc raised its stake in CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after acquiring an additional 248 shares during the period. Roxbury Financial LLC lifted its holdings in CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC boosted its position in CVS Health by 418.9% during the second quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares during the period. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Performance

NYSE:CVS opened at $80.03 on Friday. The company has a market cap of $101.60 billion, a price-to-earnings ratio of 210.62, a PEG ratio of 0.87 and a beta of 0.60. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $85.15. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83. The stock has a fifty day moving average price of $78.64 and a 200-day moving average price of $70.77.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The business had revenue of $102.87 billion during the quarter, compared to the consensus estimate of $98.85 billion. During the same quarter in the previous year, the firm earned $1.09 earnings per share. CVS Health’s revenue for the quarter was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is 700.00%.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CVS shares. Truist Financial reissued a “buy” rating and issued a $95.00 price objective (up from $92.00) on shares of CVS Health in a research report on Thursday, October 30th. Cowen reiterated a “buy” rating on shares of CVS Health in a research note on Monday, August 4th. Barclays raised their price objective on shares of CVS Health from $80.00 to $87.00 and gave the stock an “overweight” rating in a research report on Thursday, September 4th. Wolfe Research boosted their price objective on CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Monday, September 22nd. Finally, Wall Street Zen lowered CVS Health from a “buy” rating to a “hold” rating in a research note on Saturday, November 1st. Two analysts have rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $89.41.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.